Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Vallvé JC, Ferré R, Heras M, Rodríguez-Calvo R, Guaita-Esteruelas S, Martínez-Micaelo N, Plana N, Masana L.

J Clin Med. 2019 Oct 26;8(11). pii: E1793. doi: 10.3390/jcm8111793.

2.

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk.

Girona J, Amigó N, Ibarretxe D, Plana N, Rodríguez-Borjabad C, Heras M, Ferré R, Gil M, Correig X, Masana L.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3151. doi: 10.3390/ijms20133151.

3.

Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain.

Masana L, Ibarretxe D, Rodríguez-Borjabad C, Plana N, Valdivielso P, Pedro-Botet J, Civeira F, López-Miranda J, Guijarro C, Mostaza J, Pintó X; Expert group from the Spanish Arteriosclerosis Society.

Atherosclerosis. 2019 Aug;287:89-92. doi: 10.1016/j.atherosclerosis.2019.06.905. Epub 2019 Jun 20. Review.

PMID:
31238171
4.

Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.

Ibarretxe D, Rodríguez-Borjabad C, Feliu A, Bilbao JÁ, Masana L, Plana N.

Atherosclerosis. 2018 Nov;278:210-216. doi: 10.1016/j.atherosclerosis.2018.09.039. Epub 2018 Oct 1.

PMID:
30312929
5.

Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.

Plana N, Rodríguez-Borjabad C, Ibarretxe D, Ferré R, Feliu A, Caselles A, Masana L; en representación del proyecto DECOPIN.

Clin Investig Arterioscler. 2018 Jul - Aug;30(4):170-178. doi: 10.1016/j.arteri.2017.12.003. Epub 2018 Mar 27. English, Spanish.

PMID:
29602595
6.

Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.

Rodríguez-Borjabad C, Ibarretxe D, Girona J, Ferré R, Feliu A, Amigó N, Guijarro E, Masana L, Plana N; DECOPIN Group.

Atherosclerosis. 2018 Mar;270:117-122. doi: 10.1016/j.atherosclerosis.2018.01.040. Epub 2018 Jan 31.

PMID:
29407879
7.

Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis.

Masana L, Girona J, Ibarretxe D, Rodríguez-Calvo R, Rosales R, Vallvé JC, Rodríguez-Borjabad C, Guardiola M, Rodríguez M, Guaita-Esteruelas S, Oliva I, Martínez-Micaelo N, Heras M, Ferré R, Ribalta J, Plana N.

J Clin Lipidol. 2018 Mar - Apr;12(2):292-299.e3. doi: 10.1016/j.jacl.2017.12.018. Epub 2018 Jan 8. Review.

PMID:
29398429
8.

Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Heras M, Amigo N, Feliu A, Masana L, Plana N; DECOPIN Group.

J Clin Lipidol. 2018 Jan - Feb;12(1):211-218. doi: 10.1016/j.jacl.2017.10.003. Epub 2017 Oct 12.

PMID:
29102496
9.

Familial hypercholesterolemia in childhood and adolescents: A hidden reality.

Plana N, Rodríguez-Borjabad C, Ibarretxe D, Masana L.

Clin Investig Arterioscler. 2017 May - Jun;29(3):129-140. doi: 10.1016/j.arteri.2016.11.002. Epub 2017 Apr 5. English, Spanish.

PMID:
28390853

Supplemental Content

Loading ...
Support Center